Lindone

Pregabalin, the active ingredient in Lindone, is a gabapentinoid presented as an oral formulation for oral use. It is used to manage certain types of seizures and neuropathic pain conditions in adult patients.

GNH USA supplies Lindone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pregabalin is indicated for several neurological and pain‑related conditions where abnormal neuronal excitability is a key factor.

Partial onset seizures: helps reduce the frequency of seizure episodes in patients with epilepsy. Diabetic peripheral neuropathy: alleviates pain associated with nerve damage in diabetes. Postherpetic neuralgia: diminishes lingering nerve pain after shingles. Fibromyalgia: lessens widespread musculoskeletal pain and improves functional status. Generalized anxiety disorder: reduces anxiety symptoms in adults.

Pregabalin may cause a range of adverse reactions, from mild to severe. Monitoring and reporting are essential for patient safety.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Peripheral edema: swelling of the hands, feet, or ankles. - Weight gain: gradual increase in body weight. - Blurred vision: temporary visual disturbances. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Angioedema: rapid swelling of face, lips, tongue, or throat. - Severe rash or Stevens‑Johnson syndrome: extensive skin eruptions. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Myopathy: muscle weakness or pain. - Acute renal failure: sudden loss of kidney function. - Anaphylaxis: severe allergic reaction with breathing difficulty.

Pregabalin requires careful consideration of patient history and concurrent conditions before initiation.

Renal impairment: dose adjustment may be needed in patients with reduced kidney function. History of substance misuse: monitor for signs of dependence or abuse. Pregnancy and lactation: weigh potential benefits against unknown risks. Elderly patients: start with lower doses due to increased sensitivity. Concomitant CNS depressants: avoid excessive sedation when combined with alcohol or opioids. Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Pregabalin can interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Opioids: combined use may cause profound respiratory depression. - Central nervous system depressants (e.g., benzodiazepines, barbiturates): increase risk of severe sedation and impaired coordination. - Anticholinergic agents: may exacerbate cognitive impairment.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance dizziness and somnolence. - ACE inhibitors or ARBs: may increase risk of peripheral edema. - Antidiabetic drugs: monitor blood glucose as pregabalin may affect glycemic control.